A critical breakthrough in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor protector protein is frequently inactivated in several kinds of malignancies, https://madbookmarks.com/story21988764/mini-antibodies-revive-p53-new-potential-hope-for-malignant-therapy